tiprankstipranks
Trending News
More News >

Eledon Pharmaceuticals initiated with a Buy at Guggenheim

Guggenheim analyst Vamil Divan initiated coverage of Eledon Pharmaceuticals (ELDN) with a Buy rating and $9 price target

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1